Arvinas (ARVN) Equity Average (2017 - 2026)

Arvinas (ARVN) recorded quarterly Equity Average of $410.4 million in Q1 2026, down 17.79% quarter-over-quarter from $499.2 million in Q4 2025, and down 32.83% on a YoY basis from $610.9 million in Q1 2025.

Arvinas (ARVN) Equity Average (2017 - 2026) Analysis & Trends

Arvinas' Equity Average history runs 10 years deep, the most recent figure standing at $410.4 million for Q1 2026.

  • In Q1 2026, Equity Average fell 32.83% year-over-year to $410.4 million; the TTM figure through Mar 2026 stood at $410.4 million (down 32.83% YoY), while the FY2025 annual figure was $497.8 million, down 18.51% from the prior year.
  • Equity Average was $410.4 million for Q1 2026 at Arvinas, down from $499.2 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $752.5 million in Q1 2022 to a low of $410.4 million in Q1 2026.
  • Historically, Equity Average has averaged $581.3 million across 5 years, with a median of $593.1 million in 2024.
  • The sharpest annual moves came in 2024 and 2026: Equity Average climbed 28.82% in 2024, then tumbled 32.83% in 2026.
  • A 5-year view of Equity Average shows it stood at $593.2 million in 2022, then dropped by 5.83% to $558.6 million in 2023, then climbed by 2.73% to $573.8 million in 2024, then decreased by 13.02% to $499.2 million in 2025, then dropped by 17.79% to $410.4 million in 2026.
  • The last three Equity Average figures came in at $410.4 million (Q1 2026), $499.2 million (Q4 2025), and $586.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 3.50 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 783.14 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 3.76 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.01 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 21.35 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.01 Bn
9 Abivax 91.96 Bn 91.96 Bn - 516.41 Mn
10 Arvinas 492.16 Mn -122.74 Mn - 410.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 410.35 Mn
Dec 31, 2025 499.15 Mn
Sep 30, 2025 586.85 Mn
Jun 30, 2025 634.70 Mn
Mar 31, 2025 610.90 Mn
Dec 31, 2024 573.85 Mn
Sep 30, 2024 593.10 Mn
Jun 30, 2024 604.95 Mn
Mar 31, 2024 634.85 Mn
Dec 31, 2023 558.60 Mn
Sep 30, 2023 460.40 Mn
Jun 30, 2023 487.30 Mn
Mar 31, 2023 537.95 Mn
Dec 31, 2022 593.20 Mn
Sep 30, 2022 646.05 Mn
Jun 30, 2022 696.95 Mn
Mar 31, 2022 752.50 Mn
Dec 31, 2021 799.70 Mn
Sep 30, 2021 700.30 Mn
Jun 30, 2021 599.05 Mn